Harvard BioscienceHBIO
13F holders, Q2 2025 (June 30)2holders +1
0new positions
0sold out
$0.44avg. 13F price*
At the end of Q2 2025, 2 institutions reported holding Harvard Bioscience Inc. (HBIO) in their 13F filings, up 1 from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Pension & Wealth Management Advisors, Inc. ($3K) and Essential Partners LLC ($39).
- Company
- Harvard Bioscience Inc.
- CUSIP
- 416906204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 2 holders
| Pension & Wealth Management Advisors, Inc. | 0.00% | No change | 5,950 | $3K |
| Essential Partners LLC | 0.00% | — | 87 | $39 |
"% of holder's portfolio" is HBIO's weight in each manager's 13F, not the share of Harvard Bioscience Inc. the manager owns.